Your session is about to expire
← Back to Search
Education at the first follow up for Chronic Multifocal Osteomyelitis
N/A
Recruiting
Research Sponsored by Seattle Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of CRMO
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-9 months
Awards & highlights
Study Summary
This trial aims to understand how often children with CRMO at Seattle Children's Hospital do not take their medication as prescribed, and what factors might make it difficult for them to stick to their treatment plan.
Who is the study for?
This trial is for pediatric patients with Chronic Recurrent Multifocal Osteomyelitis (CRMO) being treated at Seattle Children's Hospital. The study focuses on those who have not yet received educational materials about managing their medication.Check my eligibility
What is being tested?
The study tests if giving educational materials to help manage medications improves how well kids with CRMO stick to their treatment plans. Patients are randomly placed into two groups; one gets the info after their first visit, and the other after their second visit.See study design
What are the potential side effects?
Since this trial involves education on medication management rather than a medical intervention, there are no direct side effects from drugs or treatments. However, stress or anxiety related to understanding and managing the condition could occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with CRMO.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medication possession ratio (MPR)
Secondary outcome measures
Barriers to adherence
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Education at the first follow upExperimental Treatment1 Intervention
video and AVS education will be provided at the first follow up visit
Group II: Education at baselineActive Control1 Intervention
video and ambulatory visit summary (AVS) education will be provided at baseline visit
Find a Location
Who is running the clinical trial?
University of WashingtonOTHER
1,752 Previous Clinical Trials
1,840,379 Total Patients Enrolled
Seattle Children's HospitalLead Sponsor
306 Previous Clinical Trials
5,218,279 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger